Cell Impact (OSTO:CI) EBIT per Share: kr-0.48 (TTM As of Mar. 2026)


What is Cell Impact EBIT per Share?

Cell Impact OSTO:CI -0.56% EBIT per Share is kr-0.48 as of Mar. 2026. The stock has 7 warning signs investors should review. Among 2,497 Industrial Products companies, Cell Impact ranks better than 83.22% on this metric.

Cell Impact's EBIT per Share for the three months ended in Mar. 2026 was kr-0.05. Its EBIT per Share for the trailing twelve months (TTM) ended in Mar. 2026 was kr-0.48.

During the past 3 years, the average EBIT per Share Growth Rate was 32.90% per year. During the past 5 years, the average EBIT per Share Growth Rate was 14.80% per year. During the past 10 years, the average EBIT per Share Growth Rate was -2.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.

The historical rank and industry rank for Cell Impact's EBIT per Share or its related term are showing as below:

OSTO:CI' s 3-Year EBIT Growth Rate Range Over the Past 10 Years
Min: -1281.7   Med: -4.7   Max: 33.6
Current: 32.9

During the past 13 years, the highest 3-Year average EBIT per Share Growth Rate of Cell Impact was 33.60% per year. The lowest was -1281.70% per year. And the median was -4.70% per year.

OSTO:CI's 3-Year EBIT Growth Rate is ranked better than
83.22% of 2497 companies
in the Industrial Products industry
Industry Median: 4.7 vs OSTO:CI: 32.90

Cell Impact's EBIT for the three months ended in Mar. 2026 was kr-16.56 Mil.

Cell Impact  (OSTO:CI) EBIT per Share Explanation

EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.

Cell Impact EBIT per Share Related Terms

Cell Impact EBIT per Share Historical Data

* Premium members only.

The historical data trend for Cell Impact's EBIT per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cell Impact EBIT per Share Chart

Cell Impact Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
EBIT per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only -2.02 -2.08 -5.23 -0.77 -0.63

Cell Impact Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
EBIT per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.03 -0.14 -0.11 -0.19 -0.05

Cell Impact EBIT per Share Calculation

EBIT per Share is the amount of Earnings Before Interest and Taxes (EBIT) per outstanding share of the company's stock.

Earnings Before Interest and Taxes (EBIT) is what the company earns before it expenses interest and taxes.

Cell Impact's EBIT per Share for the fiscal year that ended in Dec. 2025 is calculated as

EBIT per Share(A: Dec. 2025 )
=EBIT/Shares Outstanding (Diluted Average)
=-127.567/201.632
=-0.63

Cell Impact's EBIT per Share for the quarter that ended in Mar. 2026 is calculated as

EBIT per Share(Q: Mar. 2026 )
=EBIT/Shares Outstanding (Diluted Average)
=-16.559/351.494
=-0.05

EBIT per Share for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was kr-0.48

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBIT per Share →
What does a EBIT per Share of kr-0.48 mean?
Cell Impact (OSTO:CI) has a EBIT per Share of kr-0.48 as of Mar. 2026. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on Cell Impact and its competitors. According to the industry distribution chart, Cell Impact ranks #419 out of 2497 companies in the Industrial Products industry, placing it in the top 16.8%.
Is Cell Impact's EBIT per Share too high?
Cell Impact's current EBIT per Share is kr-0.48. Based on the distribution chart, Cell Impact ranks #419 out of 2497 companies in the Industrial Products industry, which is in the top quartile — a strong position relative to peers.
How does Cell Impact's EBIT per Share compare to CRS and ATI?
According to the Industrial Products industry distribution chart, Cell Impact ranks #419 out of 2497 companies for EBIT per Share. This places Cell Impact in the top 17% of its industry — outperforming the majority of peers. The industry median EBIT per Share is 4.70. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT per Share for an Industrial Products company?
The median EBIT per Share among Industrial Products companies is 4.70, based on 2,497 companies in the industry. Companies in the top quartile (top 25%) have a EBIT per Share significantly above this median, while those in the bottom quartile fall well below. However, EBIT per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT per Share mean?
A high EBIT per Share can signal that a stock is expensive relative to its fundamentals. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on Cell Impact and its competitors. For the Industrial Products industry, the median EBIT per Share is 4.70 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Cell Impact's current EBIT per Share is kr-0.48. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cell Impact stock overvalued right now?
Based on GuruFocus' analysis, Cell Impact (OSTO:CI) is currently considered Modestly Overvalued. The stock's GF Value™ is kr0.06, compared to a current price of kr0.07 — trading 18.7% above its estimated fair value. The current EBIT per Share is kr-0.48. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT per Share calculated?
EBIT per Share is calculated from a company's financial statements. For Cell Impact (OSTO:CI), the current EBIT per Share is kr-0.48 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Cell Impact Business Description

Other Exchanges ICL:Germany
Address Kallmossvagen 7A, Karlskoga, SWE, 691 52
Cell Impact develops and manufactures flow plates for fuel cells and electrolyzers using materials such as graphite, stainless steel, and titanium. The company has developed and patented a high-velocity forming method, known as Cell Impact Forming, which enables the production of flow plates with advanced designs. Geographically, it operates in Sweden, Asia, the U.S., and Other Europe. It generates the majority of its revenue from Sweden.